APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $18M invested in Aptevo Therapeutics in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.32M
2
+$764K

Top Sellers

1
-$2.41M
2
-$948K
3
-$873K
4
Northern Trust
Northern Trust
Illinois
-$513K
5
Morgan Stanley
Morgan Stanley
New York
-$456K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$69K
27
$63K
28
$62K
29
$62K
30
$62K
31
$55K
32
$51K
33
$47K
34
$44K
35
$42K
36
$42K
37
$42K
38
$38K
39
$31K
40
$28K
41
$28K
42
$28K
43
$24K
44
$23K
45
$23K
46
$23K
47
$22K
48
$21K
49
$21K
50
$12K
1
2
3 4